Michael Schwartz received the prestigious Endocrine Society Ray O. Greep Award for Outstanding Research. This annual award recognizes meritorious contributions to research in endocrinology. Schwartz holds the Robert H. Williams Chair in Medicine at the University of Washington in Seattle, Wash. where he has been on faculty since 1996. He’s published over 260 peer-reviewed studies that have shaped our understanding of how the brain regulates energy balance and glucose homeostasis. His work investigating the central actions of leptin on energy balance and glucose metabolism over the last two decades has provided a novel avenue for developing weight-loss therapeutics. His lab currently focuses on the anti-diabetic effects of members of the FGF family, including FGF19, FGF21 and FGF1. A key long-term goal of these studies is to translate the findings into novel approaches for treating T2D.